Methimazole disrupted skeletal ossification and muscle fiber transition in Bufo gargarizans larvae
Methimazole (MMI) is an emerging endocrine disrupting chemical (EDC) due to its increasing use in the treatment of thyrotoxicosis (hyperthyroidism), but its potential impact on amphibian development remains largely unexplored. In the present study, the effects of 8 mg/L MMI and 1 μg/L thyroxine (T4)...
Saved in:
| Main Authors: | Fei Wei, Xueyi Wu, Hongyuan Wang, Yongpu Zhang, Lei Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Ecotoxicology and Environmental Safety |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S014765132500020X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy of a unique topical dose of methimazole in cats – A case presentation
by: Andreea Pap, et al.
Published: (2022-06-01) -
Methimazole-Related Substances: Structural Characterization and <i>In Silico</i> Toxicity Assessment
by: Leo Štefan, et al.
Published: (2024-12-01) -
The Crosstalk Between Cartilage and Bone in Skeletal Growth
by: Frank Hernández-García, et al.
Published: (2024-11-01) -
Osteoarthritis as an evolutionary legacy: Biological ageing and chondrocyte hypertrophy
by: Peter M. van der Kraan
Published: (2025-09-01) -
Notch1 signaling regulates Sox9 and VEGFA expression and governs BMP2-induced endochondral ossification of mesenchymal stem cells
by: Jing Zou, et al.
Published: (2025-05-01)